Zhejiang Wecome Pharmaceutical Company Limited (300878.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
Sector
Healthcare
Industry
Biotechnology
Employees
535
First IPO Date
August 24, 2020
| Name | Title | Pay | Year Born |
| Jing Wang | Finance Director & Accounting Supervisor | 0 | 1987 |
| Jianming Wu | Deputy GM & Non-Independent Director | 0 | 1966 |
| Zhang Qi Zhang | Deputy General Manager | 0 | 1984 |
| Dong Liu | Deputy General Manager | 0 | 1990 |
| Yang Liu | Chairman & GM | 0 | 1991 |
| Xiaoxia Kong | Deputy GM & Director | 0 | 1982 |
| Jingwei Ding | Deputy General Manager | 0 | 1974 |
| Ting Zhu | Secretary & Non-Independent Director | 0 | 1989 |
Zhejiang Wecome Pharmaceutical Company Limited primarily focuses on the innovation, manufacturing, and distribution of pharmaceutical products. Beyond its core medicinal offerings, the company also provides a range of healthcare items, over-the-counter (OTC) medications, and traditional Chinese remedies. These products are available in numerous formats, including hard and soft capsules, tablets, granules, and pills, among other dosage forms. Established in 2000, the firm, previously known as Zhejiang Weikang Pharmaceutical Co., Ltd., is headquartered in Lishui, China.